Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 189 Total
DSS - DSS Inc - Stock Price Chart
TickerDSS [AMEX]
CompanyDSS Inc
CountryUSA
IndustryPackaging & Containers
Market Cap12.58MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y22.12%
P/S-EPS next 5Y-
P/B0.13EPS Q/Q39.55%
Dividend-Sales Q/Q-64.47%
Insider Own59.23%Inst Own2.32%
Insider Trans14.21%Inst Trans-40.52%
Short Float0.55%Earnings-
Analyst Recom1.00Target Price30.43
Avg Volume8.66K52W Range1.40 - 9.36
DSS, Inc. engages in the development and distribution of paper products designed to protect valuable information from unauthorized scanning, copying, and digital imaging. It operates through the following segments: Product Packaging, Commercial Lending, Biotechnology, Direct Marketing, and Securities and Investment Management. The Product Packaging segment operates in the paper board folding carton, smart packaging, and document security printing markets. The Commercial Lending segment provides commercial loans and on acquiring equity positions in undervalued commercial bank(s), bank holding companies and non-banking licensed financial companies operating in the United States, Southeast Asia, Taiwan, Japan, and South Korea. The Biotechnology segment invests in or acquires companies in the bio-health and biomedical fields, including businesses focused on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases. The Direct Marketing segment provides services to assist companies in the emerging growth gig business model of peer-to-peer decentralized sharing marketplaces. The Securities and Investment Management segment develops and acquires assets and investments in the securities trading and funds management arena and to pursue, among other product and service lines, real estate investment funds, broker dealers and mutual funds management. The company was founded on June 16, 1984 and is headquartered in West Henrietta, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wu William Wai LeungDirectorDec 29 '23Sale0.13150,00019,6500Jan 02 04:15 PM
Wu William Wai LeungDirectorDec 29 '23Sale0.131,0201340Jan 02 04:15 PM
Chan Heng Fai AmbroseDirectorDec 28 '23Buy0.15672,17398,13719,586,499Jan 02 09:10 AM
UUUU - Energy Fuels Inc - Stock Price Chart
TickerUUUU [AMEX, RUT]
CompanyEnergy Fuels Inc
CountryUSA
IndustryUranium
Market Cap1.10BEPS (ttm)-0.07
P/E-EPS this Y-119.40%
Forward P/E24.55EPS next Y327.24%
PEG-EPS past 5Y-
P/S25.10EPS next 5Y-
P/B2.86EPS Q/Q-96.92%
Dividend-Sales Q/Q29.64%
Insider Own2.45%Inst Own51.25%
Insider Trans1.42%Inst Trans10.04%
Short Float18.86%EarningsMay 03/a
Analyst Recom1.00Target Price9.99
Avg Volume3.05M52W Range5.16 - 9.02
Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HERRERA JAQUELINEDirectorMay 13 '24Buy6.202,58416,02137,998May 14 06:42 PM
HERRERA JAQUELINEDirectorMay 10 '24Buy6.091,3958,49635,414May 14 06:42 PM
Bennett Nathan ReedCAO / Interim CFOMay 08 '24Buy5.881,5008,82017,012May 09 11:39 AM
Kirkwood Robert W.DirectorMay 07 '24Buy5.8417,200100,431228,475May 08 06:59 PM
Chalmers MarkPresident & CEOMay 07 '24Buy5.8616,83898,671940,673May 07 02:54 PM
AIRS - Airsculpt Technologies Inc - Stock Price Chart
TickerAIRS [NASD, RUT]
CompanyAirsculpt Technologies Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap268.28MEPS (ttm)0.03
P/E185.66EPS this Y29.76%
Forward P/E9.14EPS next Y40.37%
PEG-EPS past 5Y-18.66%
P/S1.36EPS next 5Y-
P/B3.21EPS Q/Q51700.00%
Dividend-Sales Q/Q3.94%
Insider Own77.52%Inst Own23.96%
Insider Trans0.00%Inst Trans0.42%
Short Float15.82%EarningsMay 10/b
Analyst Recom2.50Target Price6.00
Avg Volume67.31K52W Range4.12 - 9.94
AirSculpt Technologies, Inc. is a fat removal treatment under its brand, Elite Body Sculpture.. It provides custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. The company was founded by Aaron J. Rollins in 2012 and is headquartered in Miami Beach, FL.
AUTL - Autolus Therapeutics plc ADR - Stock Price Chart
TickerAUTL [NASD]
CompanyAutolus Therapeutics plc ADR
CountryUnited Kingdom
IndustryBiotechnology
Market Cap764.30MEPS (ttm)-1.20
P/E-EPS this Y40.21%
Forward P/E-EPS next Y18.79%
PEG-EPS past 5Y3.32%
P/S449.59EPS next 5Y-
P/B6.86EPS Q/Q-92.78%
Dividend-Sales Q/Q-100.00%
Insider Own9.38%Inst Own92.53%
Insider Trans0.00%Inst Trans-1.84%
Short Float2.23%EarningsMay 17/b
Analyst Recom1.40Target Price10.54
Avg Volume1.57M52W Range2.01 - 7.45
Today 02:42AM Q1 2024 Autolus Therapeutics PLC Earnings Call (Thomson Reuters StreetEvents)
May-17-24 01:52PM AUTL Stock Earnings: Autolus Therapeutics Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace) +7.86%
07:42AM Autolus Therapeutics' Q1 Loss Widens, Licensing Revenue Rises (MT Newswires)
07:00AM Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates (GlobeNewswire)
May-14-24 10:00AM Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress (GlobeNewswire)
May-13-24 11:15AM Autolus Therapeutics Announces Delay of Q1 Earnings Release (MT Newswires)
07:00AM Autolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call (GlobeNewswire)
Apr-24-24 10:00AM Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO (GlobeNewswire) -6.03%
Apr-23-24 07:00AM Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 (GlobeNewswire)
Apr-02-24 07:00AM Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for obecabtagene autoleucel (obe-cel) for Patients with Relapsed/refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (B-ALL) (GlobeNewswire)
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
ELDN - Eledon Pharmaceuticals Inc - Stock Price Chart
TickerELDN [NASD]
CompanyEledon Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap73.08MEPS (ttm)-1.49
P/E-EPS this Y31.40%
Forward P/E-EPS next Y44.59%
PEG-EPS past 5Y43.37%
P/S-EPS next 5Y-
P/B1.00EPS Q/Q54.47%
Dividend-Sales Q/Q-
Insider Own5.59%Inst Own36.04%
Insider Trans0.00%Inst Trans-1.35%
Short Float0.15%EarningsMay 09/b
Analyst Recom1.00Target Price14.00
Avg Volume168.52K52W Range1.07 - 2.94
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cellular transplant, and for people living with autoimmune and neurodegenerative disease. The firm's compound in development is AT-1501, a humanized IgG1 anti-CD40L antibody with high affinity for CD40 ligand (CD40L, also called CD154), a well-validated biological target with broad therapeutic potential. The CD40L/CD40 pathway is recognized for its prominent role in immune regulation, making it a candidate for therapeutic intervention in transplant tolerance, autoimmune disease, and neuro-inflammation. The company is building upon a deep historical understanding of the CD40/CD40L pathway, as well as preclinical and Phase 1 data, to initiate up to four phase 2 clinical studies with AT-1501. Eledon Pharmaceuticals was founded on March 26, 2004 and is headquartered in Irvine, CA.
VOXR - Vox Royalty Corp - Stock Price Chart
TickerVOXR [NASD]
CompanyVox Royalty Corp
CountryCanada
IndustryOther Precious Metals & Mining
Market Cap113.98MEPS (ttm)0.01
P/E303.33EPS this Y-
Forward P/E65.00EPS next Y366.67%
PEG-EPS past 5Y69.47%
P/S9.82EPS next 5Y-
P/B2.55EPS Q/Q68.21%
Dividend2.02%Sales Q/Q-19.50%
Insider Own28.52%Inst Own17.26%
Insider Trans0.00%Inst Trans-
Short Float0.19%EarningsMay 08/a
Analyst Recom1.25Target Price4.11
Avg Volume101.38K52W Range1.70 - 2.93
Vox Royalty Corp. operates as a growth and precious metals focused mining royalty and streaming company. It holds a portfolio of 36 royalties and streaming assets and 1 royalty option spanning seven jurisdictions. The company was founded by Kyle Floyd on January 22, 2014 and is headquartered in George Town, Cayman Islands.
NRIX - Nurix Therapeutics Inc - Stock Price Chart
TickerNRIX [NASD, RUT]
CompanyNurix Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap984.12MEPS (ttm)-2.65
P/E-EPS this Y-9.70%
Forward P/E-EPS next Y-8.58%
PEG-EPS past 5Y-59.00%
P/S12.17EPS next 5Y-
P/B4.83EPS Q/Q-0.31%
Dividend-Sales Q/Q30.74%
Insider Own6.52%Inst Own80.64%
Insider Trans-0.91%Inst Trans-4.59%
Short Float12.45%EarningsApr 10/b
Analyst Recom1.33Target Price24.67
Avg Volume1.08M52W Range4.22 - 18.12
Nurix Therapeutics, Inc. is a clinical stage biopharmaceutical company. It engages in the business of discovering, developing, and commercializing innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer, inflammatory conditions, and other challenging diseases. The company was founded by John Kuriyan, Michael Rape, and Arthur Weiss in 2009 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
van Houte HansChief Financial OfficerMay 02 '24Sale12.833,49944,87868,333May 02 06:01 PM
Hansen GwennChief Scientific OfficerApr 30 '24Option Exercise0.005,206041,608Apr 30 06:33 PM
Ring ChristineChief Legal OfficerApr 30 '24Option Exercise0.003,924021,351Apr 30 06:33 PM
van Houte HansChief Financial OfficerApr 30 '24Option Exercise0.004,886073,219Apr 30 06:33 PM
Hansen GwennChief Scientific OfficerApr 30 '24Sale12.042,00724,16939,601Apr 30 06:33 PM
BACK - IMAC Holdings Inc - Stock Price Chart
TickerBACK [NASD]
CompanyIMAC Holdings Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap3.89MEPS (ttm)-13.61
P/E-EPS this Y57.26%
Forward P/E-EPS next Y0.00%
PEG-EPS past 5Y10.09%
P/S0.46EPS next 5Y-
P/B-EPS Q/Q94.42%
Dividend-Sales Q/Q-100.00%
Insider Own17.94%Inst Own13.69%
Insider Trans0.00%Inst Trans-
Short Float18.53%Earnings-
Analyst Recom1.00Target Price8.00
Avg Volume1.01M52W Range1.22 - 7.75
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. Its services include medical treatments, regenerative medicine, physical medicine, physical therapy, spinal decompression and chiropractic manipulation. The company was founded by Matthew C. Wallis, Jason William Brame and Jeffrey S. Ervin in August 2000 and is headquartered in Franklin, TN.
ATUS - Altice USA Inc - Stock Price Chart
TickerATUS [NYSE]
CompanyAltice USA Inc
CountryUSA
IndustryTelecom Services
Market Cap1.04BEPS (ttm)0.01
P/E164.96EPS this Y58.38%
Forward P/E21.81EPS next Y-45.47%
PEG-EPS past 5Y35.28%
P/S0.11EPS next 5Y-0.20%
P/B-EPS Q/Q-181.51%
Dividend-Sales Q/Q-1.88%
Insider Own55.41%Inst Own51.51%
Insider Trans0.00%Inst Trans2.95%
Short Float11.56%EarningsMay 02/b
Analyst Recom2.90Target Price2.68
Avg Volume3.79M52W Range1.75 - 3.82
Altice USA, Inc. engages in the provision of broadband, pay television, telephony services, proprietary content, and advertising services. Its brands include Optimum, Suddenlink, Optimum Mobile, Altice Business, News 12 Networks, Cheddar News, a4 Advertising, and i24 News. The company was founded by Patrick Drahi in 2001 and is headquartered in Long Island City, NY.
SVM - Silvercorp Metals Inc - Stock Price Chart
TickerSVM [AMEX]
CompanySilvercorp Metals Inc
CountryCanada
IndustrySilver
Market Cap702.42MEPS (ttm)0.17
P/E22.94EPS this Y75.92%
Forward P/E13.70EPS next Y36.90%
PEG4.59EPS past 5Y-16.09%
P/S3.40EPS next 5Y5.00%
P/B1.37EPS Q/Q-12.01%
Dividend0.63%Sales Q/Q-0.24%
Insider Own4.57%Inst Own31.48%
Insider Trans0.00%Inst Trans-9.62%
Short Float1.30%EarningsMay 23/a
Analyst Recom1.25Target Price5.13
Avg Volume2.10M52W Range2.08 - 3.98
Silvercorp Metals, Inc. engages in the acquisition, exploration, development, and mining of mineral properties. It operates through Mining and Administrative segments. The Mining segment includes Henan Luoning, Guangdong, and others. The Administrative segment focuses on Vancouver and Beijing. The company was founded by Rui Feng on October 31, 1991 and is headquartered in Vancouver, Canada.
15678910111213141519